The Ministry of Health (MOH) is currently working to strengthen access to these therapies. Shifting demand and the challenge of non-medical use Another trend influencing access is the growing public interest in weight-loss medications
These drugs work by mimicking the hormone GLP-1 to interact with neural pathways that signal satiety (fullness) and slow stomach emptying, leading to reduced food intake
If you average five workouts a week and only want to take the pre- and post-workouts and meal replacement on gym days, then the stack will last you a month, with some BCAAs to spare
Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I
3.2 Cuproptosis Cuproptosis is a newly recognized type of cell death, and the process involves reliance on copper, accumulation of proteins modified with fatty acids, and reduction of Fe-S cluster proteins (Tsvetkov et al., 2022)
Managing Joint Pain While Taking GLP-1 Medications Topical NSAIDs are NICE-recommended first-line for localised joint pain, alongside low-impact exercise, adequate hydration, and gradual activity progression
